Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341).
J Med Chem
; 58(10): 4278-90, 2015 May 28.
Article
in En
| MEDLINE
| ID: mdl-25905990
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Experimental
/
Thiadiazoles
/
Receptors, Glucocorticoid
/
Cytochrome P-450 Enzyme Inhibitors
/
Heterocyclic Compounds, 3-Ring
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
United States